Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05658081

Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study

Conditions: Crohn Disease, Recurrence

Sex: All
Ages: 16 Years – 60 Years
Phase: NA
Enrollment: 236
Sponsor: Jinling Hospital, China

Location: China

Summary

The postoperative recurrence of Crohn's diseases (CD) remains high. Stapled anti-mesenteric functional end-to-end anastomosis was safe for CD patients. Its impact on the postoperative recurrence of CD was unknown. Whether it is superior than the conventional anastomosis (stapled antimesenteric isoperistaltic side-to-side anastomosis) needs explored. The trial aims to compare the different impacts of the two antimesenteric anastomosis configurations on the anastomotic recurrence following bowel resection.

Eligibility Criteria

Inclusion Criteria:patients with Crohn's disease needing bowel resection and anastomosis;ileocolic anastomosis;written consent acquiredExclusion Criteria:patients underwent enterostomy;small bowel anastomosis;anticipating other trial.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05658081). StuddyBuddy aggregates publicly available trial information.